DE2411856A1 - 6 beta-acylamido-1-oxadethiapenicillansaeuren - Google Patents

6 beta-acylamido-1-oxadethiapenicillansaeuren

Info

Publication number
DE2411856A1
DE2411856A1 DE2411856A DE2411856A DE2411856A1 DE 2411856 A1 DE2411856 A1 DE 2411856A1 DE 2411856 A DE2411856 A DE 2411856A DE 2411856 A DE2411856 A DE 2411856A DE 2411856 A1 DE2411856 A1 DE 2411856A1
Authority
DE
Germany
Prior art keywords
acid
compound
radical
substituted
oxadethiapenicillanic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE2411856A
Other languages
German (de)
English (en)
Inventor
Burton Grant Christensen
Ronald William Ratcliffe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2411856A1 publication Critical patent/DE2411856A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE2411856A 1973-03-13 1974-03-12 6 beta-acylamido-1-oxadethiapenicillansaeuren Ceased DE2411856A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34080273A 1973-03-13 1973-03-13
US39751673A 1973-09-17 1973-09-17
US43274074A 1974-01-17 1974-01-17

Publications (1)

Publication Number Publication Date
DE2411856A1 true DE2411856A1 (de) 1974-09-19

Family

ID=27407422

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2411856A Ceased DE2411856A1 (de) 1973-03-13 1974-03-12 6 beta-acylamido-1-oxadethiapenicillansaeuren

Country Status (9)

Country Link
JP (1) JPS5029592A (enExample)
AR (1) AR214161A1 (enExample)
CH (1) CH616938A5 (enExample)
DE (1) DE2411856A1 (enExample)
ES (1) ES424204A1 (enExample)
FR (1) FR2221123B1 (enExample)
GB (1) GB1458410A (enExample)
NL (1) NL7402539A (enExample)
SE (1) SE417206B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639397A1 (de) * 1975-09-03 1977-03-10 Smithkline Corp 7-oxo-1,3-diazabicyclo eckige klammer auf 3.2.o eckige klammer zu heptan-2-carbonsaeure-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE2702091A1 (de) * 1976-01-27 1977-07-28 Beecham Group Ltd Azabicycloheptanon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2552764A1 (fr) * 1983-05-17 1985-04-05 Chinoin Gyogyszer Es Vegyeszet Derives cephalosporaniques et penicillaniques semi-synthetiques contenant du phosphore, procede de preparation de ces derives et compositions pharmaceutiques les contenant
JPH029786Y2 (enExample) * 1986-12-02 1990-03-12
JP5418814B2 (ja) 2009-03-13 2014-02-19 山本光学株式会社 ゴーグル

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577408A (en) * 1968-10-15 1971-05-04 American Home Prod Tetrahydro-2-oxofuran penicillins
CA1024518A (en) * 1972-04-10 1978-01-17 Queen's University Azetidinones and their production and use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639397A1 (de) * 1975-09-03 1977-03-10 Smithkline Corp 7-oxo-1,3-diazabicyclo eckige klammer auf 3.2.o eckige klammer zu heptan-2-carbonsaeure-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE2702091A1 (de) * 1976-01-27 1977-07-28 Beecham Group Ltd Azabicycloheptanon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate

Also Published As

Publication number Publication date
SE417206B (sv) 1981-03-02
GB1458410A (en) 1976-12-15
FR2221123A1 (enExample) 1974-10-11
AR214161A1 (es) 1979-05-15
FR2221123B1 (enExample) 1977-01-28
JPS5029592A (enExample) 1975-03-25
ES424204A1 (es) 1976-10-16
AU6629874A (en) 1975-09-11
NL7402539A (enExample) 1974-09-17
CH616938A5 (en) 1980-04-30

Similar Documents

Publication Publication Date Title
DE1445154C3 (de) 1,4-Dihydro-1,8-naphthyridinderi vate und ein Verfahren zu ihrer Herstellung
DE2751624A1 (de) 1-carba-2-penem-3-carbonsaeure
DE2819479C2 (enExample)
EP0096297B1 (de) Verfahren zur Herstellung von 1-Sulfo-2-oxoazetidinderivaten
DE2461526C2 (de) N-Acylderivate von α-Aminobenzylpenicillinen
CH634567A5 (de) Verfahren zur herstellung von uracilderivaten.
DE69131753T2 (de) Antibakterielle penem-esterderivate
DE1153023B (de) Verfahren zur Herstellung von 4-Hydroxy-pyrazolo[3,4-d] pyrimidinen
CH624670A5 (en) Process for preparing an oxoazetidine derivative as a stereospecific intermediate for the synthesis of cephalosporins
DE2312041A1 (de) Penicilline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DE2411856A1 (de) 6 beta-acylamido-1-oxadethiapenicillansaeuren
DE2826546A1 (de) Imidazoldicarbonsaeure-derivate
DE3044970C2 (enExample)
DE69131774T2 (de) Antibakterielle penem-ester derivate
DE2612926A1 (de) Neue acyl-derivate der 6-(alpha- amino-phenylacetamido)-penicillansaeure
DE2215039A1 (de) Neue Acyloxyalkylesterderivate von Penicillin und Cephalosporin
DE2501638A1 (de) Verfahren zur epimerisierung von penicillinverbindungen
EP0722946A1 (de) Verfahren zur Herstellung von 3-Formyl-Cephem-Derivaten
DE3743111A1 (de) Dierythromycin- und dicholinsalze von (3s(z))-2-(((1-(2-amino-4-thiazolyl)-2-((2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl)-amino)-2-oxoaethyliden)-amino)-oxy)-essigsaeure
DE2450668A1 (de) Ureidobenzylpenicilline und verfahren zu ihrer herstellung
EP0350445A1 (de) Substituierte Azacyclohexyl-Derivate
DE3204074A1 (de) Neue 1-benzyl-4-(4-(2-pyrimidinylamino)-benzyl)-2,3-dioxopiperazin-derivate, salze derselben, verfahren zur herstellung derselben und carcinostatische mittel mit einem gehalt derselben
CH645905A5 (de) Cephalosporinderivate, verfahren fuer ihre herstellung und antibakteriell wirkende zusammensetzungen, die solche verbindungen enthalten.
AT332974B (de) Verfahren zur herstellung neuer penicilline
AT340587B (de) Verfahren zur herstellung neuer cephemderivate

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: ABITZ, W., DIPL.-ING.DR.-ING. MORF, D., DR., PAT.-

8110 Request for examination paragraph 44
8131 Rejection